The man's family later sued OptumRx and Walgreens, claiming they didn't offer alternatives after his regular inhaler's price increased dramatically.
High-volume production justifies investments in automation—such as robotic valve assembly and inline dose testing—that reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results